Scarica l'app Stockscreener
3.015
1.52%
0.045
Precedente Chiudi:
$2.97
Aprire:
$2.98
Volume 24 ore:
5,564
Relative Volume:
0.16
Capitalizzazione di mercato:
$1.87M
Reddito:
-
Utile/perdita netta:
$-17.06M
Rapporto P/E:
-0.0426
EPS:
-70.7173
Flusso di cassa netto:
$-14.18M
1 W Prestazione:
-5.19%
1M Prestazione:
-50.08%
6M Prestazione:
-53.90%
1 anno Prestazione:
-89.40%
Intervallo 1D:
$2.95
$3.03
Intervallo di 1 settimana:
$2.95
$3.32
Portata 52W:
$2.95
$55.20
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Nome
Cns Pharmaceuticals Inc
Settore
Industria
Telefono
1-800-946-9185
Indirizzo
2100 WEST LOOP SOUTH, HOUSTON
Compare CNSP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
3.015 | 1.84M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
482.93 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
775.86 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
836.38 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.58 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
350.45 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-12-28 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Iniziato | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Borsa (CNSP) Ultime notizie
Price Action: Will CNS Pharmaceuticals Inc stock go up in YEARGDP Growth & Smart Investment Allocation Tips - baoquankhu1.vn
Breakout Watch: Is CNS Pharmaceuticals Inc currently under institutional pressure2025 Support & Resistance & Verified Technical Trade Signals - baoquankhu1.vn
Is CNS Pharmaceuticals Inc. forming a bullish divergence2025 AllTime Highs & Expert Verified Movement Alerts - mfd.ru
Chart Watch: How does CNS Pharmaceuticals Inc perform in inflationary periodsGold Moves & Safe Capital Growth Plans - baoquankhu1.vn
CNS Pharmaceuticals appoints three new executives to leadership team - Investing.com South Africa
CNS Pharmaceuticals appoints three new executives to leadership team By Investing.com - Investing.com Canada
ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Potential 41.67% Upside Amid Robust CNS Drug Portfolio - DirectorsTalk Interviews
CNS Pharmaceuticals appoints Steven O’Loughlin as CFO, Dylan Wenke as CBO - TipRanks
CNS Pharmaceuticals Restructures Finance Leadership, Appoints New CFO - TipRanks
CNS Pharmaceuticals, Inc. Announces Chief Financial Officer Changes, Effective March 2, 2026 - marketscreener.com
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation - Yahoo Finance
Levels Update: Is CNS Pharmaceuticals Inc currently under institutional pressure2025 Performance Recap & Low Risk Growth Stock Ideas - baoquankhu1.vn
Is CNS Pharmaceuticals Inc. currently under institutional pressureFed Meeting & Free Long-Term Investment Growth Plans - mfd.ru
Is CNS Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Sector Review & Risk Managed Investment Strategies - mfd.ru
How CNS Pharmaceuticals Inc. stock performs in weak economy2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
What are analysts’ price targets for CNS Pharmaceuticals Inc.July 2025 Opening Moves & Long Hold Capital Preservation Tips - mfd.ru
Why CNS Pharmaceuticals Inc. stock is recommended by analystsInsider Selling & Entry Point Strategy Guides - mfd.ru
CNS Pharmaceuticals (NASDAQ:CNSP) Shares Down 11.2% – Here’s What Happened - Defense World
Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook on CNS Drug Innovator with 19.56% Upside Potential - DirectorsTalk Interviews
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - MSN
Growth Report: Will Origin Bancorp Inc outperform the market in YEARPrice Action & Community Verified Trade Signals - baoquankhu1.vn
Weekly Trades: Why is CNS Pharmaceuticals Inc stock going downJuly 2025 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
Aug Catalysts: Will CNS Pharmaceuticals Inc outperform small cap indexesQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn
Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire
CNS Pharmaceuticals shares dip after CEO departure announcement - MSN
CNS Pharmaceuticals says priority ‘is to transform’ how company operates - TipRanks
CNS Pharmaceuticals’ new CEO outlines strategic overhaul By Investing.com - Investing.com Canada
CNS Pharmaceuticals (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287 - Digital Journal
CNS Pharmaceuticals Announces Strategic Review Focused on Lead Drug Candidate TPI 287 - citybuzz -
CNS Pharmaceuticals (CNSP) CEO Outlines Strategic Vision for Fut - GuruFocus
CNS Pharmaceuticals’ new CEO outlines strategic overhaul - Investing.com
CNS Pharmaceuticals Issues Letter to Shareholders - ACCESS Newswire
New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug - stocktitan.net
Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots - Seeking Alpha
Breakout Move: Is CNS Pharmaceuticals Inc stock good for income investorsMarket Volume Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Up 3.3% – What’s Next? - Defense World
Is CNS Pharmaceuticals Inc. being accumulated by smart money2025 Major Catalysts & Precise Buy Zone Identification - bollywoodhelpline.com
CNS Pharma Stock Up Over 30% - Nasdaq
Weekly Trades: Is CNS Pharmaceuticals Inc in a long term uptrendJuly 2025 Fed Impact & Verified Short-Term Plans - baoquankhu1.vn
How CNS Pharmaceuticals Inc. stock compares to market leadersForecast Cut & AI Optimized Trading Strategy Guides - ulpravda.ru
How CNS Pharmaceuticals Inc. stock reacts to global recession fears2025 Price Targets & Growth Focused Investment Plans - Улправда
How CNS Pharmaceuticals Inc. stock performs after earningsJuly 2025 Summary & Detailed Earnings Play Alerts - Улправда
Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Earnings Risk Summary & Reliable Volume Spike Alerts - Улправда
Dividend Watch: How CNS Pharmaceuticals Inc. stock performs in rate cut cycles2025 Investor Takeaways & Accurate Trade Setup Notifications - Улправда
CNS Pharmaceuticals Inc. (CNSP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Down 0.5% – Here’s Why - Defense World
Aug Reactions: How CNS Pharmaceuticals Inc stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn
CNS Pharmaceuticals names Rami Levin as new CEO following John Climaco’s departure - MSN
Whats Driving Tourism Finance Corporation of India Limited Stocks Recent Momentum Key TrendsCandlestick Trading Patterns & High Return Capital Strategies - earlytimes.in
Why CNS Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
Will CNS Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Growth vs Value & Safe Entry Trade Signal Reports - Улправда
Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.12%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):